A clinical trial looking at maintaining hydration at the end of life
Not Applicable
- Conditions
- Patients in the last week of life (cancer, non-malignant disease)Not Applicable
- Registration Number
- ISRCTN65858561
- Lead Sponsor
- niversity of Surrey
- Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36418131/ (added 24/11/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 1600
Inclusion Criteria
1. Aged =18 years
2. Estimated prognosis of =1 week
3. Patient unable to maintain sufficient oral fluid intake (i.e. <1l/day).
Exclusion Criteria
1. Patient is dehydrated (patient eligible for inclusion after correction of dehydration)
2. Patient has a relevant Advance Directive to Refuse Treatment (ADRT)
3. Clinical indication for CAH
4. Clinical contraindication to CAH
5. Contraindication to cannulation
6. Total parenteral nutrition/enteral feeding in situ
7. Patient has had delirium in last 24 h
8. Patient has had audible upper airway secretions in last 24 h
9. Patient likely to be transferred elsewhere for end-of-life care
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method